| Literature DB >> 27626680 |
Yuyan Wei1, Kai Li1, Shaohua Yao2, Junping Gao1, Jun Li1, Yanna Shang3, Jie Zhang1, Le Zhang1, Yanyan Li1, Xianming Mo3, Wentong Meng3, Rong Xiang4, Jiankun Hu5, Ping Lin1, Yuquan Wei2.
Abstract
Human zinc finger protein 32 (ZNF32) is a Cys2-His2 zinc-finger transcription factor that plays an important role in cell fate, yet much of its function remains unknown. Here, we reveal that the zebrafish ZNF32 homologue zfZNF32 is expressed in the nervous system, particularly in the lateral line system. ZfZNF32 knock-out zebrafish (zfZNF-/-) were generated using the CRISPR-associated protein 9 system. We found that the regenerative capacity of the lateral line system was increased in zfZNF-/- upon hair cell damage compared with the wild type. Moreover, SOX2 was essential for the zfZNF32-dependent modulation of lateral line system regeneration. Mechanistic studies showed that ZNF32 suppressed SOX2 transcription by directly binding to a consensus sequence (5'-gcattt-3') in the SOX2 promoter. In addition, ZNF32 localizes to the nucleus, and we have identified that amino acids 1-169 (Aa 1-169) and each of three independent nuclear localization signals (NLSs) in ZNF32 are indispensable for ZNF32 nuclear trafficking. Mutating the NLSs disrupted the inhibitory effect of ZNF32 in SOX2 expression, highlighting the critical role of the NLSs in ZNF32 function. Our findings reveal a pivotal role for ZNF32 function in SOX2 expression and regeneration regulation.Entities:
Keywords: DNA binding site; NLS; SOX2; ZNF32; regeneration
Mesh:
Substances:
Year: 2016 PMID: 27626680 PMCID: PMC5342562 DOI: 10.18632/oncotarget.11895
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1ZfZNF32 expression pattern during early embryonic development
A. ZfZNF32 mRNA was distributed uniformly from the zygote stage to the larval stage according to Q-PCR. B. Agarose gel electrophoresis of the (A) PCR product. C. Whole-mount in situ hybridization revealed the dynamic expression of zfZNF32 during zebrafish development (from the 1 cell stage to 5 dpf), and zfZNF32 was mainly restricted to the nervous system and pectoral fin (lateral view and dorsal view), as indicated by arrows.
Figure 2Establishment of zfZNF32 knock-out zebrafish and lateral line system regeneration
A. Agarose gel electrophoresis showing the Cas9-mediated zfZNF with bases deleted compared with WT. B. A total of 85 bp were deleted (in blue font) in the zfZNF. C. The regenerative capacity of the lateral line system was increased in 4 dpf zfZNF at 12 and 24 hrs after neomycin treatment. Hair cells in the lateral line were stained with DASPEI (red fluorescence). The L1 was chosen as the representative regenerating neuromast, as indicated by arrows, and shown in the lower right corner of each figure with 200×magnification.
Figure 3ZNF32 negatively regulates SOX2 expression in vivo and in vitro
A. The early nerve stem cell factors nestin, SOX2 and olig2 were detected by WISH at 32 hpf in zfZNF and WT. mRNA expression is indicated by arrows. B. WISH revealed SOX2 expression in zfZNF and WT at bud, 24 hpf and 48 hpf stages. SOX2 mRNA expression is indicated by arrows. C. The regenerative capacity of the lateral line system was decreased in 4 dpf zfZNF microinjected with SOX2 MO compared with control MO at 24 hrs after neomycin treatment. Hair cells in the lateral line were stained with DASPEI (red fluorescence). The L1 was chosen as the representative regenerating neuromast, as indicated by arrows, and shown in the lower right corner of each figure with 200×magnification. Relative gene expression of ZNF32 and SOX2 in BE(2)-C cell lines was detected at the mRNA level by Q-PCR D. and at the protein level by western blotting E. Untreated BE(2)-C cells served as controls. BE(2)-C lv-NC and BE(2)-C lv-ZNF32 cells were transiently transfected with pSG5-Vec and pSG5-ZNF32. Q-PCR and western blotting were performed to detect the relative expression of ZNF32 and SOX2 at the mRNA F. and protein level G. All of the quantitative values are presented as the means±S.D. *P< 0.05, **P< 0.01. NS, not significant.
Figure 4ZNF32 directly binds the SOX2 promoter to suppress SOX2 transcription
A. The DNA binding sites were identified by CASTing. The DNA sequences of the 22 clones are shown. B. Analyses of the sequences of the 22 clones revealed the ZNF32-DNA binding site as 5′- g(a/c/t)attt -32. C. The 2-kb region upstream of the human SOX2 promoter was from the NCBI web server. Blue characters mark the DNA binding site, 5′- gcattt -32, located at -1545. D. EMSA revealed that the SOX2 probe was preferentially bound by the ZNF32 protein compared with GST, and the binding capacity was weakened as competitive probe was added in vitro. The band shift revealed the protein-DNA binding capacity. E. EMSA showing that protein-probe binding corresponded to nuclear ZNF32 protein expression. Nuclear proteins were isolated from the BE(2)-C stable cell lines lv-NC (lane 1), lv-ZNF32 (lane 2), LV6-NC (lane 3), LV6-ZNF32 (lane 4). The band shift changed with the ZNF32 expression level. F. GFP-ChIP PCR results indicated that ZNF32 over-expression increased the protein-DNA binding ability, suggesting that ZNF32 specifically binds the SOX2 promoter sequence. IgG was used as a negative control.
Figure 5Bioinformatics prediction and the importance of Aa 1-169 of ZNF32
A. Screenshot from the PDB predicting the zinc-finger motifs and secondary/tertiary structural components. B. Screenshot from EMBL-EBI web server showing the α-helixes and β-sheets predicted in ZNF32. C, E. Schematic representation of the recombinant, GFP-tagged ZNF32 mutant proteins. Lines represent the deleted sequences in the proteins. D, F. The subcellular localization of ZNF32 mutant proteins. Recombinant proteins are shown in green (GFP), and cell nuclei are shown in blue (DAPI). Scale bar = 50 μm.
Figure 6Identification of NLSs in ZNF32 and the localization of NLS mutants
A, B. ZNF32 NLS 1 (Aa 170-185). (A) Schematic representation of recombinant, GFP-tagged ZNF32 mutant proteins. Lines represent the deleted sequences in the proteins. (B) The subcellular localization of ZNF32 and NLS 1 mutant proteins. Recombinant proteins are shown in green (GFP), and cell nuclei are shown in blue (DAPI). C, D. ZNF32 NLS 2 (Aa 186-199). The basic amino acids Lys and Arg were replaced with Ala in NLS 2 mutant. (C) Schematic representation of the recombinant, GFP-tagged ZNF32 mutants. Lines represent the deleted sequences in the proteins. (D) The subcellular localization of ZNF32 and NLS 2 mutant. Recombinant proteins are shown in green (GFP), and cell nuclei are shown in blue (DAPI). E, F. ZNF32 NLS 3 (Aa 227-239). (E) Schematic representation of the recombinant, GFP-tagged ZNF32 mutants. Lines represent the deleted sequences in the proteins. (F) The subcellular localization of ZNF32 and NLS 3 mutant. Recombinant proteins are shown in green (GFP), and cell nuclei are shown in blue (DAPI). Scale bar = 50 μm.
Figure 7The NLSs of ZNF32 influence SOX2 expression
Several NLS-mutant ZNF32 plasmids, pEGFP-1-169-NLS 1, pEGFP-1-169-NLS 2, pEGFP-1-169-NLS 3, pEGFP-1-169-NLS 1-NLS 2, pEGFP-1-169-NLS 1-NLS 3, pEGFP-1-169-NLS 2-NLS 3 and pEGFP-ZNF32, were transiently transfected into BE(2)-C cells. pEGFP-N1 was used as a negative control. The effects on SOX2 expression were detected by Q-PCR A. and western blotting B. All of the quantitative values are presented as the means±S.D. *P< 0.05, **P< 0.01, ***P< 0.001. NS, not significant.
Primers used in this study
| Genes | Primers (up) | Primers (dw) |
|---|---|---|
Primers used for zfZNF32 plasmid construction, Q-PCR gene amplification, ChIP assay and Cas9 mediated zfZNF screening.